Portal Vein Thrombosis
📧 Sign up to get email alerts when something new happens for Portal Vein Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion [Phase 2]
Phase 2 trial evaluating proton beam radiotherapy followed by atezolizumab (Tecentriq) and bevacizumab (Avastin) for hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis [Phase 4]
Phase 4 pharmacokinetic study of apixaban to prevent portal hypertension complications in cirrhosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS [NA]
Clinical trial update assessing the efficacy of apixaban for portal vein thrombosis occurring more than one year after LS; the study is curr…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD [NA]
A clinical trial is evaluating the efficacy of apixaban for portal vein thrombosis occurring more than one year after liver disease in patie…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Indicators Affecting PVT Recanalization
This clinical trial from Shanghai Zhongshan Hospital is recruiting to evaluate indicators associated with recanalization of portal vein thro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
This clinical trial registry entry investigates the incidence and outcomes of portal vein thrombosis in liver cirrhosis and the role of anti…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT [Phase 2]
A completed Phase 2 trial evaluating hepatic arterial infusion chemotherapy combined with Lenvatinib and PD-1 inhibitors for advanced hepato…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes
This completed clinical trial evaluates portal vein stenting for malignant obstruction, reporting on feasibility and safety and detailing ob…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Intraoperative Endovascular Treatment Via the Ligamentum Teres Hepatis in Liver Transplantation for Yerdel Grade Ⅲ/IV Portal Vein Thrombosis: A Safe and Effective Strategy
A completed clinical trial evaluating intraoperative endovascular treatment via the ligamentum teres hepatis during liver transplantation in…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation
A clinical trial update describing a study that investigates the correlation between portal vein thrombosis and prognosis after liver transp…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy and safety of anticoagulants in patients with cirrhosis, with or without hepatocellular …
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Endoscopic Ultrasound-guided Measurement of Portal Vein Pressure Gradient [NA]
This clinical trials update describes a study evaluating endoscopic ultrasound-guided measurement of the portal vein pressure gradient for p…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause.
Completed clinical trial investigating risk factors for recurrence or extension of thrombosis in acute non-cirrhotic portal vein thrombosis …
-
CLINICAL_TRIALS withdrawal · 2025-03-26Clinical Trial Update: Chances in Portal System Flow After Two Bariatric Procedures [NA]
This clinical trial has been withdrawn; it studied changes in portal vein flow after two bariatric procedures.
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT） [Phase 4]
A Phase 4 trial assessed whether apixaban, warfarin, and aspirin can prevent portal vein thrombosis after laparoscopic splenectomy in patien…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy [Phase 2]
A Phase 2 neoadjuvant trial comparing atezolizumab/bevacizumab versus neoadjuvant radiation therapy in hepatocellular carcinoma with portal …
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis [Phase 2, Phase 3]
ClinicalTrials.gov listing for a Phase 2/3 trial comparing dabigatran to enoxaparin in patients with portal vein thrombosis and cirrhosis, n…
-
CLINICAL_TRIALS withdrawal · 2025-01-14Clinical Trial Update: Large-Bore Mechanic Thrombectomy for the Treatment of Symptomatic Portomesenteric Vein Thrombosis
Clinical trial NCT06318754 evaluating large-bore mechanical thrombectomy for symptomatic portomesenteric vein thrombosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis [Phase 2]
Phase 2 trial comparing sorafenib plus hepatic arterial infusion versus sorafenib alone in hepatocellular carcinoma with major portal vein t…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Freiburg TIPS Registry
Clinical trial update for Freiburg's TIPS Registry showing ongoing recruitment for a registry study of portal hypertension-related condition…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis [Phase 2]
A Phase 2 clinical trial evaluating H101 in combination with transarterial chemoembolization (TACE) for primary hepatocellular carcinoma wit…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT [Phase 3]
Phase 3 trial comparing SBRT+TACE+Sorafenib versus Sorafenib alone in unresectable hepatocellular carcinoma with portal vein thrombosis.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Safety of Anticoagulant Therapy After Endoscopic Treatment [Phase 4]
Phase 4 trial update assessing the safety of anticoagulant therapy after endoscopic treatment in patients with cirrhosis and portal vein thr…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis. [Phase 3]
Phase 3 trial updating on the prevention of recurrent thrombosis with Xarelto compared to no treatment in patients with chronic portal vein …
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis [Phase 4]
Phase 4 clinical trial updating the efficacy and safety of anticoagulant therapy in patients with portal vein thrombosis and liver cirrhosis…